FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

1274211000001100: Zafirlukast 20mg tablets 56 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22699901000001119 Zafirlukast 20mg tablets 56 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22700001000001117 Zafirlukast 20mg tablets 56 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

6 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zafirlukast 20mg tablets 56 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zafirlukast 20mg tablets 56 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Zafirlukast 20mg tablets 56 tablet VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Zafirlukast 20mg tablets 56 tablet Is pack of Product containing precisely zafirlukast 20 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Zafirlukast 20mg tablets 56 tablet Has active ingredient Musculoskeletal system agent false Inferred relationship Existential restriction modifier
Zafirlukast 20mg tablets 56 tablet Has active ingredient Zafirlukast false Inferred relationship Existential restriction modifier
Zafirlukast 20mg tablets 56 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zafirlukast 20mg tablets 56 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Zafirlukast 20mg tablets 56 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Zafirlukast 20mg tablets 56 tablet Has VMP Product containing precisely zafirlukast 20 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Zafirlukast 20mg tablets 56 tablet Has specific active ingredient Zafirlukast true Inferred relationship Existential restriction modifier
Zafirlukast 20mg tablets 56 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Zafirlukast 20mg tablets 56 tablet VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Accolate 20mg tablets (AstraZeneca) 56 tablet 4 x 14 tablets Is a True Zafirlukast 20mg tablets 56 tablet Inferred relationship Existential restriction modifier
Accolate 20mg tablets (PI) (Waymade Ltd) 56 tablet 4 x 14 tablets Is a True Zafirlukast 20mg tablets 56 tablet Inferred relationship Existential restriction modifier
Accolate 20mg tablets (PI) (Dowelhurst Ltd) 56 tablet 4 x 14 tablets Is a True Zafirlukast 20mg tablets 56 tablet Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Doncaster Pharmaceuticals Ltd) 56 tablet Is a True Zafirlukast 20mg tablets 56 tablet Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Sigma Pharmaceuticals Plc) 56 tablet Is a True Zafirlukast 20mg tablets 56 tablet Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) 56 tablet Is a True Zafirlukast 20mg tablets 56 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start